Cargando…

The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease

Parkinson’s disease (PD) is a common and progressive neurodegenerative disease, caused by the loss of dopaminergic neurons in the substantia nigra pars compacta in the midbrain, which is clinically characterized by a constellation of motor and non-motor manifestations. The latter include hyposmia, c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magistrelli, Luca, Contaldi, Elena, Comi, Cristoforo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401994/ https://www.ncbi.nlm.nih.gov/pubmed/34440548 http://dx.doi.org/10.3390/life11080804

Ejemplares similares

Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient
por: Contaldi, Elena, et al.
Publicado: (2021)

T Lymphocytes in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2022)

Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2021)

Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
por: Contaldi, Elena, et al.
Publicado: (2022)

Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson’s Disease: A Single-Center Longitudinal Study
por: Contaldi, Elena, et al.
Publicado: (2022)

The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease
por: Martini, Stefano, et al.
Publicado: (2023)

Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know?
por: Magistrelli, Luca, et al.
Publicado: (2022)

Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
por: Magistrelli, Luca, et al.
Publicado: (2021)

The Length of SNCA Rep1 Microsatellite May Influence Cognitive Evolution in Parkinson’s Disease
por: Corrado, Lucia, et al.
Publicado: (2018)

Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study
por: Contaldi, Elena, et al.
Publicado: (2021)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

Network Analysis Implicates Alpha-Synuclein (Snca) in the Regulation of Ovariectomy-Induced Bone Loss
por: Calabrese, Gina, et al.
Publicado: (2016)

SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex
por: Brown, Jennifer L., et al.
Publicado: (2022)

Targeted attenuation of elevated histone marks at SNCA alleviates α‐synuclein in Parkinson's disease
por: Guhathakurta, Subhrangshu, et al.
Publicado: (2021)

Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding
por: Wurster, Isabel, et al.
Publicado: (2022)

Alpha-Synuclein and Parkinson’s Disease Motor and Non-Motor Symptoms: What Is New?
por: Grigoletto, Jessica, et al.
Publicado: (2022)

Regulation of Αlpha-Synuclein Gene (SNCA) by Epigenetic Modifier TET1 in Parkinson Disease
por: Guhathakurta, Subhrangshu, et al.
Publicado: (2022)

Alpha‐synuclein mRNA isoform formation and translation affected by polymorphism in the human SNCA 3ʹUTR
por: Barrie, Elizabeth S., et al.
Publicado: (2018)

Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence
por: Magistrelli, Luca, et al.
Publicado: (2019)

The Effects of COVID-19-Related Restrictions on Parkinson’s Disease Patients in Italy: Results of a Structured Survey
por: Martini, Stefano, et al.
Publicado: (2022)

α‐Synuclein antisense transcript SNCA‐AS1 regulates synapses‐ and aging‐related genes suggesting its implication in Parkinson's disease
por: Rey, Federica, et al.
Publicado: (2021)

Alpha‐synuclein dynamics in induced pluripotent stem cell‐derived dopaminergic neurons from a Parkinson’s disease patient (PARK4) with SNCA triplication
por: Fukusumi, Hayato, et al.
Publicado: (2021)

SNCA-AS1 in aging and Parkinson’s disease
por: Carelli, Stephana, et al.
Publicado: (2022)

SNCA Rep1 microsatellite length influences non-motor symptoms in early Parkinson’s disease
por: Yong, Alisa CW, et al.
Publicado: (2020)

Preclinical reserpine models recapitulating motor and non-motor features of Parkinson’s disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment
por: Li, Yang, et al.
Publicado: (2022)

The SNCA-Rep1 Polymorphic Locus: Association with the Risk of Parkinson’s Disease and SNCA Gene Methylation
por: Iakovenko, E. V., et al.
Publicado: (2020)

A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain
por: Cronin, Kenneth D., et al.
Publicado: (2009)

SNCA Triplication Parkinson's Patient's iPSC-derived DA Neurons Accumulate α-Synuclein and Are Susceptible to Oxidative Stress
por: Byers, Blake, et al.
Publicado: (2011)

SNCA Gene Methylation in Parkinson’s Disease and Multiple System Atrophy
por: Fedotova, Ekaterina Yu., et al.
Publicado: (2023)

Genetic Variants of the α-Synuclein Gene SNCA Are Associated with Multiple System Atrophy
por: Al-Chalabi, Ammar, et al.
Publicado: (2009)

Snca-GFP Knock-In Mice Allows Tracking the Endogenous α-Synuclein in Action
por: Er, Safak
Publicado: (2021)

Genetic Impact on Clinical Features in Parkinson's Disease: A Study on SNCA-rs11931074
por: Shu, Li, et al.
Publicado: (2018)

Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
por: Gallegos, Scarlet, et al.
Publicado: (2015)

Piperine promotes autophagy flux by P2RX4 activation in SNCA/α-synuclein-induced Parkinson disease model
por: Li, Ruolin, et al.
Publicado: (2021)

The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease
por: Lau, Heather H. C., et al.
Publicado: (2023)

Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
por: Luo, Ningdi, et al.
Publicado: (2019)

Transmission of alpha-synuclein in Parkinson’s disease
por: Lee, Virginia M-Y
Publicado: (2013)

Alpha-synuclein spreading in Parkinson’s disease
por: Recasens, Ariadna, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v3412o4ao8ino4cj3ev0sjjsf6